|1 Table of Contents 3
|1.1 List of Tables 6
|1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Aesthetic Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Aesthetic Devices Market, South Korea 15
3.1 Aesthetic Devices Market, South Korea, Revenue ($m), 2018-2033 15
3.2 Aesthetic Devices Market, South Korea, Revenue Mix ($m), 2023 17
3.3 Aesthetic Devices Market, South Korea, Category Contribution by Revenue ($m), 2023 18
3.4 Aesthetic Devices Market, South Korea, Revenue ($m), 2018-2033 20
3.5 Aesthetic Devices Market, South Korea, Volume (Units), 2018-2033 22
3.6 Aesthetic Devices Market, South Korea, Volume (Units), 2018-2033 24
3.7 Aesthetic Devices Market, South Korea, Company Share by Revenue ($m), 2023 27
4 Aesthetic Implants Market, South Korea 29
4.1 Aesthetic Implants Market, South Korea, Revenue Mix ($m), 2023 29
4.2 Aesthetic Implants Market, South Korea, Segment Contribution (%), 2023 30
4.3 Aesthetic Implants Market, South Korea, Revenue ($m), 2018-2033 32
4.3.1 Breast Implants Market, South Korea, Revenue ($m), by Segment, 2018-2033 34
4.3.2 Face Implants Market, South Korea, Revenue ($m), by Segment, 2018-2033 36
4.3.3 Penile Implants Market, South Korea, Revenue ($m), by Segment, 2018-2033 38
4.4 Aesthetic Implants Market, South Korea, Volume (Units), 2018-2033 40
4.4.1 Breast Implants Market, South Korea, Volume (Units), by Segment, 2018-2033 42
4.4.2 Face Implants Market, South Korea, Volume (Units), by Segment, 2018-2033 44
4.4.3 Penile Implants Market, South Korea, Volume (Units), by Segment, 2018-2033 46
4.5 Aesthetic Implants Market, South Korea, Average Price ($), 2018-2033 48
4.6 Aesthetic Implants Market, South Korea, Distribution Share by Revenue ($m), 2018-2033 50
4.7 Aesthetic Implants Market, South Korea, Company Share by Revenue ($m), 2023 51
5 Aesthetic Injectables Market, South Korea 53
5.1 Aesthetic Injectables Market, South Korea, Revenue Mix ($m), 2023 53
5.2 Aesthetic Injectables Market, South Korea, Segment Contribution (%), 2023 54
5.3 Aesthetic Injectables Market, South Korea, Revenue ($m), 2018-2033 56
5.3.1 Hyaluronic Acid Fillers Market, South Korea, Revenue ($m), by Segment, 2018-2033 58
5.3.2 Non Hyaluronic Acid Fillers Market, South Korea, Revenue ($m), by Segment, 2018-2033 60
5.4 Aesthetic Injectables Market, South Korea, Volume (Units), 2018-2033 62
5.4.1 Hyaluronic Acid Fillers Market, South Korea, Volume (Units), by Segment, 2018-2033 64
5.4.2 Non Hyaluronic Acid Fillers Market, South Korea, Volume (Units), by Segment, 2018-2033 66
5.5 Aesthetic Injectables Market, South Korea, Average Price ($) , 2018-2033 68
5.6 Aesthetic Injectables Market, South Korea, Distribution Share by Revenue ($m), 2018-2033 69
5.7 Aesthetic Injectables Market, South Korea, Company Share by Revenue ($m), 2023 70
6 Body Contouring Devices Market, South Korea 72
6.1 Body Contouring Devices Market, South Korea, Revenue Mix ($m), 2023 72
6.2 Body Contouring Devices Market, South Korea, Segment Contribution (%), 2023 73
6.3 Body Contouring Devices Market, South Korea, Revenue ($m), 2018-2033 75
6.3.1 Minimally Invasive Body Contouring Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033 77
6.3.2 Non Invasive Body Contouring Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033 79
6.4 Body Contouring Devices Market, South Korea, Volume (Units), 2018-2033 81
6.4.1 Minimally Invasive Body Contouring Devices Market, South Korea, Volume (Units), by Segment, 2018-2033 83
6.4.2 Non Invasive Body Contouring Devices Market, South Korea, Volume (Units), by Segment, 2018-2033 85
6.5 Body Contouring Devices Market, South Korea, Average Price ($) , 2018-2033 87
6.6 Body Contouring Devices Market, South Korea, Distribution Share by Revenue ($m), 2018-2033 89
6.7 Body Contouring Devices Market, South Korea, Company Share by Revenue ($m), 2023 90
7 Laser Resurfacing Devices Market, South Korea 92
7.1 Laser Resurfacing Devices Market, South Korea, Revenue Mix ($m), 2023 92
7.2 Laser Resurfacing Devices Market, South Korea, Segment Contribution (%), 2023 93
7.3 Laser Resurfacing Devices Market, South Korea, Revenue ($m), 2018-2033 95
7.3.1 Multi Technology Combination Laser Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033 97
7.3.2 Single Technology Laser Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033 99
7.4 Laser Resurfacing Devices Market, South Korea, Volume (Units), 2018-2033 101
7.4.1 Multi Technology Combination Laser Devices Market, South Korea, Volume (Units), by Segment, 2018-2033 103
7.4.2 Single Technology Laser Devices Market, South Korea, Volume (Units), by Segment, 2018-2033 105
7.5 Laser Resurfacing Devices Market, South Korea, Average Price ($) , 2018-2033 107
7.6 Laser Resurfacing Devices Market, South Korea, Distribution Share by Revenue ($m), 2018-2033 108
7.7 Laser Resurfacing Devices Market, South Korea, Company Share by Revenue ($m), 2023 109
8 Overview of Key Companies in South Korea, Aesthetic Devices Market 111
8.1 Galderma SA 111
8.1.1 Company Overview 111
8.2 Allergan Aesthetics 111
8.2.1 Company Overview 111
8.3 Mentor Worldwide LLC 111
8.3.1 Company Overview 111
8.4 Cynosure Inc 111
8.4.1 Company Overview 111
8.5 Candela Corp 112
8.5.1 Company Overview 112
8.6 HansBiomed Co Ltd 112
8.6.1 Company Overview 112
8.7 Boston Scientific Corp 112
8.7.1 Company Overview 112
8.8 Merz Pharma GmbH & Co KgaA 112
8.8.1 Company Overview 112
8.9 Establishment Labs SA 113
8.9.1 Company Overview 113
8.10 Solta Medical Inc 113
8.10.1 Company Overview 113
9 Aesthetic Devices Market Pipeline Products 114
10 Financial Deals Landscape 115
10.1 Acquisition 115
10.1.1 Incredible Debt Acquires Additional Stake in Motiva Korea for USD15 Million 115
10.2 Debt Offerings 116
10.2.1 Bioplus to Raise USD43.20 Million in Private Placement of Convertible Bonds 116
10.3 Equity Offerings 117
10.3.1 Dongbang Medical Files Prospectus to Raise Upto USD38.25 Million in Initial Public Offering (IPO) of Shares 117
10.4 Merger 118
10.4.1 Classys to Merge With Ilooda (Iruda) For USD93.6 Million 118
10.5 Partnerships 119
10.5.1 BNC Korea Enters into Distribution Agreement with Dongkook Pharma 119
10.5.2 Dongkook Pharma to Enter into Research Agreement with Shaperon (Chaperone) 120
10.6 Private Equity 121
10.6.1 Carlyle Group Plans to Acquire Jeisys Medical (Jsis Medical) 121
10.7 Venture Financing 122
10.7.1 Mediver Secures USD1.08 Million in Pre Series A Funding 122
11 Recent Developments 123
11.1 Legal And Regulatory 123
11.1.1 Mar 18, 2025: Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance 123
11.2 Product News 123
11.2.1 Feb 14, 2025: MAYPHARM Launches SKINCOLLA: The World's First Recombinant Human Collagen Filler for Superior Skin Rejuvenation 123
11.2.2 Jan 16, 2025: Hugel Vows to Become Global Leader at J.P. Morgan Healthcare Conference 124
11.2.3 Dec 30, 2024: Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration 124
11.2.4 Nov 11, 2024: CGBIO to Launch Calcium Filler ‘FACETEM’ in Taiwan Signaling a Major Shift in Asian Aesthetic Market Landscape 125
11.2.5 Sep 10, 2024: “Dermatologic Surgery” Journal Publishes Special Issue on Neuromodulators 126
11.2.6 Jul 24, 2024: Dongkook Pharmaceutical Announces Medical Aesthetics Line HA Filler 'Cablelin' Launch Symposium 127
11.3 Strategy And Business Planning 128
11.3.1 Nov 21, 2024: Hugel and Medica Partner to Boost Botulinum Toxin Sales in Middle East, North Africa 128
12 Appendix 129
12.1 Research Methodology 130
12.1.1 Coverage 130
12.1.2 Secondary Research 130
12.1.3 Primary Research 131
12.1.4 Market Modeling and Forecasting 131
12.1.5 Company Share Analysis 133
12.1.6 Distribution Share Analysis 133
12.1.7 Benchmarking 133
12.2 GlobalData Consulting 134
12.3 Contact Us 134
12.4 Disclaimer 134